A drug from the specified list | SOP Information, SOPs and Supporting Information – alphabetic listing, Q to Z, Retinal Vascular Occlusive Disease F059, Rulebase for retinal vascular occlusive disease

You are here

A drug from the specified list

Document

Retinal vascular occlusive disease - A drug from the specified list Factor

Last reviewed for CCPS 05 October 2006.

Investigative Documents

Claimant Report - Use of a Specified Drug [CR9265]

Medical Report - Use of a Specified Drug [MR9344]

Preliminary questions [36281]

36327

there is some evidence that using a drug from the specified list for retinal vascular occlusive disease may be a factor in the development of the condition under consideration.

36329 the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease.

36330the veteran has established the causal connection between using a drug from the specifed list for retinal vascular occlusive disease and VEA service for the clinical onset of retinal vascular occlusive disease.

36331the veteran has established the causal connection between using a drug from the specifed list for retinal vascular occlusive disease and operational service for the clinical onset of retinal vascular occlusive disease.

or

36332the veteran has established the causal connection between using a drug from the specifed list for retinal vascular occlusive disease and eligible service for the clinical onset of retinal vascular occlusive disease.

Clinical onset and operational service [36331]

36333

on operational service, the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease.

36334

the veteran's use of a drug from the specified list for retinal vascular occlusive disease on operational service, within the 72 hours before the clinical onset of retinal vascular occlusive disease, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

36335

the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease as a consequence of an illness or injury which is identifiable.

36336the identified illness or injury, as a consequence of which the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease, is causally related to operational service.

Clinical onset and eligible service [36332]

38755

on eligible service, the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease.

38756

the veteran's use of a drug from the specified list for retinal vascular occlusive disease on eligible service, within the 72 hours before the clinical onset of retinal vascular occlusive disease, was due to the veteran's serious default, wilful act or serious breach of discipline.

38757

the veteran's use of a drug from the specified list for retinal vascular occlusive disease on eligible service, within the 72 hours before the clinical onset of retinal vascular occlusive disease, occurred as a causal result of eligible service.

or

36335

the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease as a consequence of an illness or injury which is identifiable.

36337the identified illness or injury, as a consequence of which the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease, is causally related to eligible service.